A carregar...
Safety concerns about intravenous iron therapy in patients with chronic kidney disease
Anaemia in chronic kidney disease (CKD) is managed primarily with erythropoiesis-stimulating agents (ESAs) and iron therapy. Following concerns around ESA therapy, intravenous (IV) iron is being administered more and more worldwide. However, it is still unclear whether this approach is safe at very...
Na minha lista:
Publicado no: | Clin Kidney J |
---|---|
Main Authors: | , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Oxford University Press
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4792617/ https://ncbi.nlm.nih.gov/pubmed/26985378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfv142 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|